Drawing for 1 POINT

USPTO serial 86731782

1 POINT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
PRATER, JILL I
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with 1 POINT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karl M. Zielaznicki, Esq.

Karl M. Zielaznicki, Esq. Troutman Sanders LLP875 Third Avenuec/o IP Services NYCNew York, NY 10022

Goods and services

ClassDescriptionStatusFirst use
035Business administration of patient reimbursement program; Business administration of medication reimbursement programsABANDONED—
036Providing insurance information and insurance reimbursement information; providing financial assistance for prescription costsABANDONED—
042Providing medical and scientific research information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders and regarding pharmaceutical products relating to the management of hematological malignancies, cancer, auto-immune diseases and inflammatory diseases and disordersABANDONED—
044Providing medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; providing medical information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer, auto-immune diseases and inflammatory diseases and disordersABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 8, 2020MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Jan 8, 2020ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jan 8, 2020OP.TOPPOSITION TERMINATED NO. 999999—
Jan 8, 2020CTDDCT DECISION: DISMISSED—
Sep 23, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 23, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 25, 2019OP.SOPPOSITION SUSTAINED NO. 999999—
Jun 22, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 15, 2016OP.IOPPOSITION INSTITUTED NO. 999999—
Jun 2, 2016ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 17, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 17, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 27, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 5, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 24, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 23, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 23, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 23, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2015DOCKASSIGNED TO EXAMINER—
Aug 27, 2015MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Aug 26, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 24, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance